| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3. |
| Purification: |
Affinity purification |
| Concentration: |
Lot specific |
| Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
IGSF8 |
| Gene ID: |
93185 |
| Uniprot ID: |
IGSF8_HUMAN |
| Immunogen Region: |
28-350 |
| Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 28-350 of human IGSF8 (NP_443100.1). |
| Immunogen Sequence: |
REVLVPEGPLYRVAGTAVSI SCNVTGYEGPAQQNFEWFLY RPEAPDTALGIVSTKDTQFS YAVFKSRVVAGEVQVQRLQG DAVVLKIARLQAQDAGIYEC HTPSTDTRYLGSYSGKVELR VLPDVLQVSAAPPGPRGRQA PTSPPRMTVHEGQELALGCL ARTSTQKHTHLAVSFGRSVP EAPVGRSTLQEVVGIRSDLA VEAGAPYAERLAAGELRLGK EGTDRYRMVVGGAQAGDAG |
| Tissue Specificity | Expressed in brain, kidney, testis, liver and placenta with moderate expression in all other tissues. Detected on a majority of B-cells, T-cells, and natural killer cells. Expressed on dendritic cells. |
| Function | Member of the immunoglobulin superfamily (IgSF) that links tetraspanin-enriched microdomains to the actin cytoskeleton and plays several important roles in innate and adaptive immunity. Acts as an inducible receptor of HSPA8 on dendritic cells to enhance the CCL21/SLC-dependent migration of activated mature dendritic cells while attenuating their antigen-specific stimulatory capacities. In complex with alpha-actinins ACTN1 and ACTN4, regulates actin dynamics in the immune synapse and subsequent T-cell activation. Inhibits the entry of several viruses such as hepatitis C Virus (HCV) or HIV-1. Mechanistically, promotes a change in CD81 organization at the plasma membrane by significantly restricting its diffusion which in turn influences CD81 interaction with Claudin-1/CLDN1, preventing CLDN1 from acting as a co-receptor required for HCV entry. Accumulates at the presynaptic terminal, the producer cell side of the virological synapse, to prevent HIV-1 Env-mediated cell-cell fusion. Highly expressed on malignant cells with antigen presentation defects, interacts with NK receptor KIR3DL2 to suppress NK-cell cytotoxicity. May participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain. |
| Protein Name | Immunoglobulin Superfamily Member 8Igsf8Cd81 Partner 3Glu-Trp-Ile Ewi Motif-Containing Protein 2Ewi-2Keratinocytes-Associated Transmembrane Protein 4Kct-4Lir-D1Prostaglandin Regulatory-Like ProteinPgrlCd Antigen Cd316 |
| Cellular Localisation | Cell MembraneSingle-Pass Membrane ProteinColocalizes With Cd81 At The Immune Synapse |
| Alternative Antibody Names | Anti-Immunoglobulin Superfamily Member 8 antibodyAnti-Igsf8 antibodyAnti-Cd81 Partner 3 antibodyAnti-Glu-Trp-Ile Ewi Motif-Containing Protein 2 antibodyAnti-Ewi-2 antibodyAnti-Keratinocytes-Associated Transmembrane Protein 4 antibodyAnti-Kct-4 antibodyAnti-Lir-D1 antibodyAnti-Prostaglandin Regulatory-Like Protein antibodyAnti-Pgrl antibodyAnti-Cd Antigen Cd316 antibodyAnti-IGSF8 antibodyAnti-CD81P3 antibodyAnti-EWI2 antibodyAnti-KCT4 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
